English Germany Japanese Korean

上海一飞生物科技有限公司 公司信息

公司名称: 上海一飞生物科技有限公司
电话: 021-65675885
电子邮件:customer_service@efebio.com
国籍:中国
网址: http://www.efebio.com
产品总数:11974
88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供产品列表

SR4554 SR4554 167648-73-9
Sulesomab 硫索单抗 167747-19-5
Felvizumab Felvizumab 167747-20-8
GNE-0946 GNE-0946 1677667-24-1
Faralimomab Faralimomab 167816-91-3
(R)-VX-11e (R)-4-(2-((2-氯-4-氟苯基)氨基)-5-甲基嘧啶-4-基)-N-(1-(3-氯苯基)-2-羟基乙基)-1H-吡咯-2-甲酰胺 1680187-43-2
DJ4 化合物DJ4 1681020-24-5
PG 34 化合物 PG 34 1681056-62-1
Propofol-d17 β-D glucuronide 丙泊酚-D17Β-D-葡糖醛酸 1683581-05-6
Rosmantuzumab Rosmantuzumab 1684393-04-1
Dyrk1A-IN-5 化合物 DYRK1A-IN-5 1685235-41-9
Cynandione A 1,1'-(2',3,6,6'-四羟基-[1,1'-联苯]-2,3'-二基)二乙酮 168706-29-4
YM-58790 化合物YM-58790 168830-70-4
αvβ1 integrin-IN-1 化合物 T13473 1689540-62-2
Flupyrimin N-[(E)-1-(6-氯-3-吡啶基)甲基-2(1H)-吡啶亚基]-2,2,2-三氟乙酰胺 1689566-03-7
Obexelimab 奥贝利单抗 1690307-05-1
Lanepitant 拉奈匹坦 170566-84-4
ARTD10/PARP10-IN-1 ARTD10/PARP10抑制剂1 1708103-76-7
1-vinylpyrene 1-乙烯 17088-21-0
Frunevetmab 夫卢维单抗 1708936-80-4
Emapalumab 依玛鲁单抗 1709815-23-5
Sodium zirconium cyclosilicate 环硅酸锆钠 17141-74-1
Igovomab 伊戈伏单抗 171656-50-1
Piprozolin 哌普唑林 17243-64-0
tert-Butyl (6-iodohexyl)carbamate TERT-BUTYL 6-IODOHEXYLCARBAMATE 172846-36-5
Inophyllum E 红厚壳（种）内酯 17312-31-1
NDH-1 inhibitor-1 N-(3,4-二甲氧基苄基)-2-萘甲酰胺 173964-49-3
(E)-3-(2-Chloro-4-fluorophenyl)acrylic acid AA 174603-37-3
Keliximab 凯利昔单抗 174722-30-6
Tidembersat TIDEMBERSAT 175013-73-7
BODIPY FL prazosin 化合物 BODIPY FL PRAZOSIN 175799-93-6
Tagatose 化合物 T34770 17598-81-1
Roxifiban acetate 化合物 T24733 176022-59-6
CYP1B1-IN-5 CYP1B1抑制剂5 176442-56-1
Izonsteride IZONSTERIDE 176975-26-1
3,4,5-Trihydroxycinnamic acid decyl ester 化合物 3,4,5-TRIHYDROXYCINNAMIC ACID DECYL ESTER 1770778-45-4
MMP2-IN-2 5-硝基-2-(4-硝基苯基)-1H-苯并咪唑 1772-39-0
Phenmedipham-d3 甜菜宁-D3 1773497-41-8
ATX-002 ATX-002 1777792-34-3
Sarizotan 2HCl SARIZOTAN 2盐酸盐 177976-12-4
Opaviraline 奥帕韦兰 178040-94-3
Telisotuzumab Telisotuzumab 1781223-80-0
BMS-599626 2HCL(714971-09-2 Free base) 化合物 BMS-599626 2HCL(714971-09-2 FREE BASE) 1781932-33-9
RKI-1447 dihydrochloride RKI 1447 dihydrochloride 1782109-09-4
ML 120B dihydrochloride MLN120B DIHYDROCHLORIDE 1782573-78-7
Xanthine amine congener hydrochloride N-(2-氨基乙基)-2-(4-(2,6-二氧代-1,3-二丙基-2,3,6,7-四氢-1H-嘌呤-8-基)苯氧基)乙酰胺盐酸盐 1783977-95-6
LDN-209929 dihydrochloride 化合物 LDN-209929 DIHYDROCHLORIDE 1784281-97-5
FK 866 hydrochloride (658084-64-1 free base) N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide Hydrochloride 1785666-54-7
NLRP3/AIM2-IN-3 化合物 NLRP3/AIM2-IN-3 1787787-60-3
Gosuranemab 1788032-39-2
UC-781 N-[4-chloro-3-(3-methylbut-2-enoxy)phenyl]-2-methyl-furan-3-carbothioamide 178870-32-1
Nav1.7-IN-3 NAV1.7-IN-3 1788872-06-9
Basiliximab 巴利昔单抗 179045-86-4
WAY-639228 N-(1-苄基哌啶-4-基)萘-2-磺酰胺 179051-05-9
Remtolumab 壬托鲁单抗 1791410-27-9
Lutikizumab Lutikizumab 1791411-57-8
Elezanumab Elezanumab 1791416-49-3
Dilpacimab Dilpacimab 1791420-09-1
(2R,5S)-Ritlecitinib 1792180-79-0 1792180-79-0
Vunakizumab Vunakizumab 1792181-33-9
SB-237376 化合物 SB-237376 179258-59-4
SB-237376 HCl Benzamide, N-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro-, hydrochloride (1:1) 179258-62-9
Porgaviximab Porgaviximab 1792982-55-8
Crizanlizumab Crizanlizumab 1690318-25-2
DP00477 化合物 DP00477 169120-56-3
CCT245232 化合物 CCT245232 1693731-14-4
SXC 2023 (R)-2-乙酰氨基-3-((4-甲基苯甲酰基)硫基)丙酸 1695562-36-7
Nonabine 诺大麻 16985-03-8
Anisperimus ANISPERIMUS 170368-04-4
Cevidoplenib Methanone, cyclopropyl[5-[[4-[4-[[(4S)-4-hydroxy-2-isoxazolidinyl]methyl]-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-1-methyl-1H-indol-3-yl]- 1703788-21-9
NLRP3-IN-13 NLRP3 抑制剂 13 1704638-35-6
AZ-PFKFB3-67 (2S)-N-[4-[[3-Cyano-1-[(3,5-dimethyl-4-isoxazolyl)methyl]-1H-indol-5-yl]oxy]phenyl]-2-pyrrolidinecarboxamide 1704741-11-6
Lanepitant 2HCl 拉奈匹坦盐酸盐 170508-05-1
Larcaviximab Larcaviximab 1792982-56-9
Cosfroviximab Cosfroviximab 1792982-57-0
ER-34122 化合物 ER-34122 179325-62-3
Sacituzumab 沙西妥珠单抗 1796566-95-4
Netakimab Netakimab 1796570-08-5
PF-04822163 化合物 T28367 1798334-07-2
GNF6702 GNF-6702 1799329-72-8
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc THALIDOMIDE-O-AMIDO-CH2-PEG3-CH2-NH-BOC 1799711-31-1
GSK180 GSK180 1799725-26-0
BCAT-IN-2 BCAT-IN-2 1800024-45-6
Vutiglabridin 化合物 VUTIGLABRIDIN 1800188-47-9
Gremubamab GREMUBAMAB (格瑞巴单抗 ) 1800381-36-5
SR12418 化合物 SR12418 1801185-08-9
Odronextamab 奥尼妥单抗 1801338-64-6
Cemiplimab Cemiplimab 1801342-60-8
RYL-552 化合物 T28636 1801444-56-3
RYL-552S 化合物 RYL-552S 1801444-69-8
Losatuxizumab Losatuxizumab 1801544-27-3
KL044 9H-Carbazole-9-acetamide, N-(2-chloro-6-cyanophenyl)- 1801856-93-8
ZY-444 化合物 ZY-444 1802650-31-2
ABBV-318 ABBV-318 1802848-94-7
Oleclumab 奥来鲁单抗 1803176-05-7
Minzasolmin 化合物 MINZASOLMIN 1802518-92-8
Oleoylestrone 雌酮 3-油酸酯 180003-17-2
GPR40 agonist 6 化合物 GPR40 AGONIST 6 1798751-25-3
Ravulizumab Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer 1803171-55-2
RN-1665 化合物 RN-1665 1803003-65-7
88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007© ChemicalBook. All rights reserved.